Watch Ticker

ProMIS Neurosciences Inc. Common Shares

Go to ProMIS Neurosciences Inc. Common Shares Website

$0.68

0.01 (1.28%)

Live

Previous Close

$0.67

Day Range

$0 - $0

Previous Day Range

$0.65 - $0.7399

Market Cap

$22.9 million USD

Day Vol.

Previous Day Vol.

927274

Currency

USD

Primary Exchange

Nasdaq

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic l...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Promis Neurosciences, Inc. - ProMIS Neurosciences Announces Private Placement Financing

ProMIS Neurosciences secured $3 million in private financing through a PIPE offering, with an additional $9 million from warrant exercises, totaling approximately $12 million in gross proceeds to advance clinical development of PMN310 and support corporate operations.

Related tickers: PMN.

Read Full Article

Delveinsight - Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight

The article discusses the growing pipeline of alpha-synuclein inhibitors, a class of investigational therapies targeting the aggregation of alpha-synuclein, a protein implicated in neurodegenerative diseases. The pipeline includes over 20 active players and 22+ pipeline therapies, with several promising candidates in various stages of clinical trials.

Related tickers: ANVS, ATHE, DNLI, HLBAY, ABBV, AZN, PRTA, RHHBY, PMN.

Read Full Article

Trending Tickers

Please sign in to view